Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Barrett Esophagus 2Neoplasms, Squamous Cell 1Neoplasms 1Carcinoma in Situ 1

Interventions

Magnetic Resonance Imaging 2Interferon beta-1b 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2valrubicin 1pembrolizumab 1fludarabine phosphate 1fludarabine 1durvalumab 1dodecyl maltoside 1apaziquone 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Proflavine 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Nicotine Replacement Therapy 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Imiquimod 1Hydroxyzine 1Histamine Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma in Situ × Proflavine × Clear all
NCT01384864 2016-01-11

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Anandasabapathy, Sharmila, M.D.

Phase EARLY_PHASE1 Completed
30 enrolled
Gastrointestinal

Barrett Esophagus, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡